// Title
// Journal
// Nr.
Projection of CKD prevalence in Europe up to 2025
NDT 2015
30 (suppl 4):iv113-iv118
R 52
Loss of function
GFR slope
Waiting Time for Second Kidney Transplantation and Mortality
CJASN 2021
(in press)
170
Predicting donor, recipient and graft survival in living donor kidney transplantation to inform pre-transplant counseling: the donor and recipient linked iPREDICTLIVING tool
Transplant Int 2020
33(7):729-739
158
Management of ESRD in elderly patients
PLOS ONE 2017
12(7):e0181345
139
Design and Implementation of the International Genetics & Translational Research in Transplantation Network (iGeneTRAIN)
Transplantation 2015
99(11):2401-12
127
Risk Calculator
CJASN 2015
10(8):1371-1379
124
Molecular pathogenesis of post-transplant Acute Kidney Injury: assessment of whole-genome mRNA and miRNA profiles
PLOS ONE 2014
9(8):e104164
115
Left atrial diameter and survival among renal allograft recipients.
CJASN 2013
8:2100-2105
114
Diet and Kidney Disease in High Risk Individuals with Type 2 Diabetes
JAMA Int Med 2013
173(18):1682-92
112
miRNA profiling discriminates types of rejection and injury in human renal allografts.
Transplantation 2013
95:835-841
111
Synthetic lethality for linking Mycophenolate Mofetil mode of action with molecular disease and drug profiles.
Mol BioSystems 2012 8(12):3197-3207
110
Sirolimus induced phosphaturia is not caused by inhibition of renal apical sodium phosphate cotransporters.
PLOS ONE 2012 7(7):e39229
109
Cost-effectiveness Analysis of Renal Replacement Therapy in Austria.
Nephrol Dial Transplant 2011 26(9):2988-95
99
Steroid donor pretreatment to prevent postischemic renal allograft failure: a randomised, controlled trial.
Ann Int Med 2010
153:222-230
97
Molecular biomarker candidates of acute kidney injury in zero-hour renal transplant needle biopsies.
Transpl Int 2011 24:143-149
96
Association of ESA hypo-responsiveness and haemoglobin variability with mortality in hemodialysis patients.
Nephrol Dial Transplant 2010 25:3701-3706
95
Impaired metabolism in donor kidney grafts after steroid pretreatment.
Transplantation Int 2010 23:796-804
93
Glucose control is associated with patient and graft survival in diabetic patients after renal transplantation.
Transplantation 2010 89:612-619
91
Biocompatibility of Peritoneal Dialysis Solutions Determined by Genomics of Human Leukocytes: A Cross-over study.
Nephrol Dial Transplant plus 2009 2:510-512
90
Hemoglobin levels above 12.5 g/dl achieved by erythropoietin stimulating agents in renal transplant recipients are associated with elevated mortality: a cohort study.
BMJ 2009 339:b4018
88
Antithymocyte globulin use for treatment of biopsy confirmed acute rejection is associated with prolonged renal allograft survival.
Transplantation Int 2010 23:64-70
87
Mycophenolate Mofetil use is associated with prolonged graft survival after kidney transplantation.
Transplantation 2009 88:1095-1100
86
Calcineurin inhibitor based immunosuppressive therapy, organ donor age and long term outcome after transplantation An analysis of interactions and associations.
Transplantation 2009 87: 1821-1829
85
Body mass index modifies the risk of cardiovascular death in proteinuric chronic kidney disease.
Nephrol Dial Transplant 2009 24:2421–2428
84
Gene expression in Passive Heymann Nephritis.
Nephron Exp Nephrol 2009 112:43-58
82
Molecular predictors of anaemia after kidney transplantation.
Nephrol Dial Transplant 2009 24:1015-1023
80
Histogenomics: Association of gene expression patterns with histological parameters in kidney biopsies.
Transplantation 2009 87:290-295
79
Biocompatibility of Hemodialysis Membranes Determined by Differential Gene Expression Analysis of Human Leukocytes: A randomized Cross-over Study.
Eur J Clin Invest 2008 38:918-924
77
Statin use is associated with prolonged survival of renal transplant recipients.
JASN 2008 19:2211-2218
74
ACE-Inhibitor or AT2-Antagonist therapy of renal transplant recipients is associated with an increase in serum potassium concentrations.
Nephrol Dial Transplant 2008 23:1742-1746
70
Gene-expression profiles and age of donor kidney biopsies obtained before transplantation distinguish medium term graft function.
Transplantation 2007 83:1048-1054
65
The Association between ACE Inhibitor or Angiotensin Receptor Blocker Use during Postischemic Acute Transplant Failure and Renal Allograft Survival.
Transplantation 2006 82:1441-1448
61
Molecular signature of mice T lymphocytes following tolerance induction by allogeneic BMT and CD40-CD40L costimulation blockade.
Transpl Int. 2006 19:146-157
56
Angiotensin-converting enzyme inhibitor or AT1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation.
J Am Soc Nephrol 2006 17:889-899
54
Transcriptional response in the unaffected kidney after contralateral hydronephrosis or nephrectomy.
Kidney Int 2005 68:2497-2507
52
Detection of coregulation in differential gene expression profiles.
BioSystems 2005 82:235-247
51
Alterations in gene expression in cadaveric vs live donor kidneys suggest impaired tubular counterbalance of oxidative stress at implantation.
Am J Transplant 2004 4:1595-1604
48
Genome wide gene expression patterns of donor kidney biopsies distinguish primary allograft function
Lab Invest 2004 84:353-361
45
SCIENTIFIC COLLABORATIONS